Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial
sTVi-RCT
Narrative Intervention to Disseminate ACT for Depression in Primary Care
2 other identifiers
interventional
40
1 country
1
Brief Summary
The overall aim of this program of research is to refine and test a newly developed storytelling video intervention (sTVi) for depressed primary care patients. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of the intervention for an eventual large-scale randomized clinical trial which would test the efficacy of sTVi in comparison to a control condition. To achieve the specific aims, the investigators will conduct a pilot randomized clinical trial (n = 40), with two treatment arms: antidepressant treatment as usual (aTAU) + sTVI vs aTAU + attention control videos.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable major-depressive-disorder
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2014
CompletedFirst Posted
Study publicly available on registry
December 8, 2014
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedDecember 4, 2024
June 1, 2022
1.8 years
December 3, 2014
December 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
4 weeks
Secondary Outcomes (4)
Client Satisfaction Questionnaire-8 (CSQ-8)
4 weeks
Acceptance and Action Questionnaire-II (AAQ-II)
4 weeks
WHO-Quality of Life-BREF (WHO-QOL-BREF)
4 weeks
WHO-Disability Assessment Schedule-II (WHO-DAS-II)
4 weeks
Study Arms (2)
aTAU + sTVi
EXPERIMENTALAntidepressant Treatment as Usual (aTAU): All participants will receive antidepressant treatment as usual provided by their primary care doctor during the study. Storytelling Video Intervention (sTVi): We will develop a series of 4 videos, each episode approximately 30 minutes long, which will illustrate the key principles of Acceptance and Commitment Therapy. In addition, we will develop an accompanying "personal journal" for participants that includes a brief self-help guide which encourages participants to write about what they learned in the videos and how they will take similar steps in their own lives to cope with depression.
aTAU + Attention Control Videos
ACTIVE COMPARATORAntidepressant Treatment as Usual (aTAU): All participants will receive antidepressant treatment as usual provided by their primary care doctor during the study. Attention Control Videos: Control participants will view videos about general mental health and well-being. Specifically, we plan to give participants 4 30-minute videos on topics including nutrition, stress reduction, movement and recreation, and becoming an educated patient. The series comes with an accompanying course guidebook. We will provide videos on the same schedule as sTVi.
Interventions
Antidepressant treatment as usual provided by participants' primary care physician plus narrative communication, video-based intervention for improving depression in primary care patients.
Antidepressant treatment as usual provided by participants' primary care physician plus videos about general mental health and well-being on the same dose and frequency as the experimental intervention.
Eligibility Criteria
You may qualify if:
- Meets DSM-5 criteria for current or lifetime major depressive disorder.
- No Lifetime diagnosis of bipolar disorder, schizophrenia, or chronic psychotic condition.
- No current hazardous illicit drug or alcohol use.
- No suicidal ideation or behavior requiring immediate attention.
- Depression symptom severity: a Quick Inventory of Depressive Symptoms (QIDS) score \>11.
- Taking an antidepressant medication for at least 6 weeks; prescribed by their primary care provider.
- Not in psychotherapy during the study period.
- Have a PCP at our enrollment site.
- If pregnant, less than 24 weeks gestation.
- English speaking.
- Aged 18 or older.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Butler Hospitallead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02916, United States
Related Publications (1)
Gaudiano BA, Davis CH, Miller IW, Uebelacker L. Pilot randomized controlled trial of a video self-help intervention for depression based on acceptance and commitment therapy: Feasibility and acceptability. Clin Psychol Psychother. 2020 May;27(3):396-407. doi: 10.1002/cpp.2436. Epub 2020 Feb 28.
PMID: 32087610BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Uebelacker, PhD
Butler Hospital/Brown University
- PRINCIPAL INVESTIGATOR
Brandon Gaudiano, PhD
Butler Hospital/Brown University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-PI
Study Record Dates
First Submitted
December 3, 2014
First Posted
December 8, 2014
Study Start
May 1, 2017
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
December 4, 2024
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share